Kardigan, Inc.

US$15.52As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KARDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$1.451B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$18
14.16%
(95.32%)
Hold 7|5|3|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.18
0.19
0.19
0.19
15.42%
16.23%
12.51%
13.84%
Revenue$M
120.0
117.2
115.3
114.0
5.15%
4.05%
(2.67%)
(7.74%)
Peers (US$1.451B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.811
(0.112)
(0.111)
EBIT/Intx
2.692
0.946
0.753
Own earn%
(32.71)
3.63
6.92
Sh yield%
33.33
59.70
54.37
Owners
Insiders/Inst%
10.27
22.70
Short interest%
2.61
SBC / revenue%
5.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
4–10
$1 testx
−0.1
Incr. ROIC%
9